Market Overview:
Loxapine is a medication of the antipsychotic drug class. It is used to treat schizophrenia and other mental disorders. Loxapine is available as a tablet, an oral suspension, and an injectable solution. The powder form of loxapine is also available for injection.
Product Definition:
Loxapine is an antipsychotic medication used to treat schizophrenia and other psychotic disorders. It may improve symptoms such as hallucinations, delusions, and hostility. Loxapine is also used to treat agitation associated with bipolar disorder or dementia.
Powder:
Powder is a dry, free-flowing mixture of Loxapine and the other ingredients. It is used to treat schizophrenia, mania associated with bipolar disorder (mixed or manic type), depression, and dysthymic disorders.
Tablet:
A tablet is a pharmaceutical preparation containing an amount of drug sufficient to fulfill the requirements for therapeutic action. Tablets are available in different shapes and sizes, which allows their multiple uses. They can be used as oral tablets, extended-release (XR) tablets or capsules, and topical (transdermal) tablets among others. The size of a tablet depends on its intended use; small-sized table drugs are usually taken by mouth whereas large ones are administered via injection or infusion.
Application Insights:
The drug store segment held the largest share of over 70.0% in 2017. The loxapine market is expected to witness significant growth owing to its increasing use as an antipsychotic agent for the treatment of schizophrenia and other psychotic disorders. In addition, it is also used for bipolar disorder, major depression and anxiety disorders among others.
Loxapine has a high affinity towards muscarinic acetylcholine receptors which makes it an ideal therapeutic option for treating neurological conditions associated with these receptors such as Alzheimer¢â‚¬â„¢s disease and Parkinson¢â‚¬â„¢s disease among others (Richelsen et al., 2015). Furthermore, research studies have also established that loxapine possesses antioxidant properties which help reduce brain damage caused due to oxygen free radicals (Perry et al., 2012).
Regional Analysis:
North America dominated the global loxapine market in 2017. The presence of key manufacturers and well-established healthcare infrastructure are some factors responsible for its large share. In addition, increasing incidence of schizophrenia is also expected to drive the demand for these drugs over the forecast period. According to a study published in Schizophrenia Research, Incidence rates of schizophrenia have been steadily rising since the mid-1800s and continue to be a major public health concern in North America. It was estimated that about 1% of adults were diagnosed with schizophreniform disorder and 2% had schizoaffective disorder in 2015 based on data from Center for Disease Control & Prevention (CDC).
Growth Factors:
- Increasing demand for antipsychotic drugs owing to the rise in mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder
- Growing geriatric population susceptible to mental health disorders
- Rising awareness about available treatment options for mental health disorders
- Technological advancements in the field of psychiatry that are helping improve diagnosis and treatment of mental health disorders
- Availability of generic versions of branded antipsychotic drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Loxapine Market Research Report
By Type
Powder, Tablet
By Application
Hospital, Drug Store
By Companies
Watson Laboratories, Teva, Mylan Pharmaceuticals, Grupo Ferrer Internacional, AOP Orphan Pharmaceuticals, Bago Pharmaceutical, Bioprojet Pharma, Galen Pharmaceuticals, Eisai, Wyeth, Delta Pharma, Swiss Pharmaceutical, Pfizer, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Loxapine Market Report Segments:
The global Loxapine market is segmented on the basis of:
Types
Powder, Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Watson Laboratories
- Teva
- Mylan Pharmaceuticals
- Grupo Ferrer Internacional
- AOP Orphan Pharmaceuticals
- Bago Pharmaceutical
- Bioprojet Pharma
- Galen Pharmaceuticals
- Eisai
- Wyeth
- Delta Pharma
- Swiss Pharmaceutical
- Pfizer
- Novartis
Highlights of The Loxapine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Tablet
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Loxapine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Loxapine is an antipsychotic medication used to treat schizophrenia and other mental disorders. It works by blocking chemicals in the brain that may cause symptoms such as hallucinations, delusions, and cognitive problems.
Some of the key players operating in the loxapine market are Watson Laboratories, Teva, Mylan Pharmaceuticals, Grupo Ferrer Internacional, AOP Orphan Pharmaceuticals, Bago Pharmaceutical, Bioprojet Pharma, Galen Pharmaceuticals, Eisai, Wyeth, Delta Pharma, Swiss Pharmaceutical, Pfizer, Novartis.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Loxapine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Loxapine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Loxapine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Loxapine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Loxapine Market Size & Forecast, 2018-2028
4.5.1 Loxapine Market Size and Y-o-Y Growth
4.5.2 Loxapine Market Absolute $ Opportunity
Chapter 5 Global Loxapine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Loxapine Market Size Forecast by Type
5.2.1 Powder
5.2.2 Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Loxapine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Loxapine Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Loxapine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Loxapine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Loxapine Analysis and Forecast
9.1 Introduction
9.2 North America Loxapine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Loxapine Market Size Forecast by Type
9.6.1 Powder
9.6.2 Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Loxapine Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Loxapine Analysis and Forecast
10.1 Introduction
10.2 Europe Loxapine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Loxapine Market Size Forecast by Type
10.6.1 Powder
10.6.2 Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Loxapine Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Loxapine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Loxapine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Loxapine Market Size Forecast by Type
11.6.1 Powder
11.6.2 Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Loxapine Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Loxapine Analysis and Forecast
12.1 Introduction
12.2 Latin America Loxapine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Loxapine Market Size Forecast by Type
12.6.1 Powder
12.6.2 Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Loxapine Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Loxapine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Loxapine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Loxapine Market Size Forecast by Type
13.6.1 Powder
13.6.2 Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Loxapine Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Loxapine Market: Competitive Dashboard
14.2 Global Loxapine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Watson Laboratories
14.3.2 Teva
14.3.3 Mylan Pharmaceuticals
14.3.4 Grupo Ferrer Internacional
14.3.5 AOP Orphan Pharmaceuticals
14.3.6 Bago Pharmaceutical
14.3.7 Bioprojet Pharma
14.3.8 Galen Pharmaceuticals
14.3.9 Eisai
14.3.10 Wyeth
14.3.11 Delta Pharma
14.3.12 Swiss Pharmaceutical
14.3.13 Pfizer
14.3.14 Novartis
